Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Diabetes

Free Subscription 20.04.2026 1 Am J Clin Nutr 1 Am J Epidemiol 1 Am J Hypertens 1 Am J Ophthalmol 1 Biochem Biophys Res Commun 2 BMC Ophthalmol 1 Br J Ophthalmol 1 Circulation 12 Diabet Med 2 Diabetes 10 Diabetes Care 25 Diabetes Obes Metab 1 Diabetologia 1 Eur J Endocrinol 1 Invest Ophthalmol Vis Sci 1 J Am Coll Cardiol 4 J Clin Endocrinol Metab 2 J Clin Invest 2 J Diabetes Complications 3 JAMA 3 Metabolism 6 N Engl J Med 1 Nutr Metab (Lond) 2 Pediatr Diabetes 1 Pediatrics 6 PLoS One 2 Retina 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Nutr

1. ALVES JM, Belcher BR, Luo Y, Chow T, et al
   Dietary Macronutrient Substitutions and Cardiometabolic Outcomes in Children With and Without Gestational Diabetes Exposure: A Cross-Sectional Analysis.
   Am J Clin Nutr. 2026 Apr 13:101313. doi: 10.1016/j.ajcnut.2026.101313.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

2. GIORGIO K, Lutsey PL, Wang W, Walker R, et al
   Evaluation of potential approaches for counting person-time in instances where no active comparator is present.
   Am J Epidemiol. 2026;195:1037-1044.
   PubMed         Abstract available
   
   

   
   Am J Hypertens

3. MOIZ A, Zolotarova T, Filion KB, Eisenberg MJ, et al
   GLP-1 Receptor Agonists and Blood Pressure: A State-of-the-Art Review of Mechanisms, Evidence, and Clinical Implications.
   Am J Hypertens. 2026;39:611-622.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

4. GUMUSTOP SS, Ding X, Zhang YS, Ploumi I, et al
   Assessing Retinal Non-Perfusion with Ultra-Widefield OCT-A: Correlations with Diabetic Retinopathy Severity and Peripheral Lesions.
   Am J Ophthalmol. 2026 Apr 10:S0002-9394(26)00199.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

5. ZHAO X, Tang X, Zhang H, Wang Z, et al
   COUP-TFII promotes macrophage-myofibroblast transition by attenuating HIF-1alpha-mediated glycolysis.
   Biochem Biophys Res Commun. 2026;815:153640.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

6. YILMAZ YC, Hayat SC, Kelebek M
   Does laser delivery mode matter? Corneal sensitivity and ocular surface changes after single-spot and multispot PRP in proliferative diabetic retinopathy.
   BMC Ophthalmol. 2026 Apr 12. doi: 10.1186/s12886-026-04806.
   PubMed        
   
   
7. SHI XN, Zhang QY, Ju CJ, Xu YC, et al
   Effects of anti-VEGF therapy on choroidal thickness in eyes with diabetic macular edema.
   BMC Ophthalmol. 2026 Apr 10. doi: 10.1186/s12886-026-04811.
   PubMed         Abstract available
   
   

   
   Br J Ophthalmol

8. LIU Y, Huang J, Ao M, Huang Y, et al
   Real-world effect of vitrectomy combined with intravitreal conbercept for treatment of vitreous haemorrhage in proliferative diabetic retinopathy (QILIN I): a prospective cohort study.
   Br J Ophthalmol. 2026 Apr 15:bjo-2025-329066. doi: 10.1136/bjo-2025-329066.
   PubMed         Abstract available
   
   

   
   Circulation

9. INOUE K, Kazi DS
   GLP-1RA Use and the Risk of Heart Failure in Patients With Diabetes: Association or Causation?
   Circulation. 2026;153:1101-1103.
   PubMed        
   
   

   
   Diabet Med

10. QIU Z, Fan F, Li Z, Sun Y, et al
    Antimicrobial peptide chensinin-1b attenuates T2DM progression in atherosclerotic ApoE(-/-) mice.
    Diabet Med. 2026;43:e70232.
    PubMed         Abstract available
    
    
11. KHAN MS, Sivanantham S, Farouk L, Lakshmareddy DR, et al
    Real-world glycaemic outcomes observed with the use of Medtronic 780G, Tandem Control-IQ and Omnipod 5 automated insulin delivery systems.
    Diabet Med. 2026;43:e70251.
    PubMed         Abstract available
    
    
12. BOEGE HL, Berube LT, Ryan RA, Deierlein AL, et al
    Receipt of postpartum diabetes screening after gestational diabetes mellitus in the United States, 2016-2022.
    Diabet Med. 2026 Apr 10:e70327. doi: 10.1111/dme.70327.
    PubMed         Abstract available
    
    
13. OLSEN MT, Norgaard K, Jensen SH, Rasmussen LM, et al
    Acute kidney injury in hospitalised patients with type 2 diabetes: Associations with continuous glucose monitoring-based glucose levels, mortality, and ICU admission.
    Diabet Med. 2026 Apr 10:e70321. doi: 10.1111/dme.70321.
    PubMed         Abstract available
    
    
14. RAYMAN G, Johnston P, Earnshaw F, Kar P, et al
    Changing trends and variation in service delivery for inpatient diabetes care in England: A national survey.
    Diabet Med. 2026 Apr 10:e70320. doi: 10.1111/dme.70320.
    PubMed         Abstract available
    
    
15. BU F, Fang C, Zheng X, Yu XJ, et al
    A multi-omics risk score enables early and personalized screening for type 2 diabetes: A population-based cohort study.
    Diabet Med. 2026 Apr 11:e70323. doi: 10.1111/dme.70323.
    PubMed         Abstract available
    
    
16. EMILIA KK, Magdalena D, Lidia G, Agnieszka S, et al
    Does faster aspart improve time in range in children with type 1 diabetes with glycaemia close to target on insulin pump therapy?
    Diabet Med. 2026 Apr 12:e70330. doi: 10.1111/dme.70330.
    PubMed         Abstract available
    
    
17. SOURIJ C, Muller A, Al-Baghdadi A, Aziz F, et al
    Safety and efficacy of intermittent fasting with or without exercise in people living with overweight or obesity and type 2 diabetes-The INTERFAST-3 study design.
    Diabet Med. 2026 Apr 15:e70328. doi: 10.1111/dme.70328.
    PubMed         Abstract available
    
    
18. BANNERMAN-WILLIAMS E, Atiase Y, van den Born BH, Chilunga FP, et al
    Risk of progression to type 2 diabetes or regression to normoglycaemia among Ghanaians with prediabetes living in Ghana and the Netherlands: The RODAM prospective study.
    Diabet Med. 2026 Apr 15:e70332. doi: 10.1111/dme.70332.
    PubMed         Abstract available
    
    
19. NOORI Y, Cote E, Clark S, Chambers H, et al
    Gestational diabetes mellitus and disordered eating behaviours: A qualitative study of online forum discussions.
    Diabet Med. 2026 Apr 17:e70322. doi: 10.1111/dme.70322.
    PubMed         Abstract available
    
    
20. HEALD A, Lllangasekera Y, Matheou A, Narayanan RP, et al
    The insulin-like growth factor system and the progression of renal complications of type 2 diabetes.
    Diabet Med. 2026 Apr 17:e70318. doi: 10.1111/dme.70318.
    PubMed         Abstract available
    
    
21. SKLAR J, Harel S, Lipska KJ, Lukasik J, et al
    When the system fails: Barriers to type 1 diabetes medication access and the emergent role of social media support.
    Diabet Med. 2026 Apr 17:e70313. doi: 10.1111/dme.70313.
    PubMed         Abstract available
    
    

    
    Diabetes

22. QIN Q, Liu L, Fang Y, Zhang M, et al
    Cooperative Action of Cathepsin K Inhibitor and hUMSC-EVs in Attenuating Ferroptosis Sensitivity for Superior Diabetic Wound Healing.
    Diabetes. 2026 Apr 14:db250817. doi: 10.2337/db25-0817.
    PubMed         Abstract available
    
    
23. MEIER CZ, Wagner R, Ganslmeier M, Kantartzis K, et al
    Different Metabolic Responses to Long-term Weight Loss After Lifestyle Intervention Among Type 2 Diabetes Risk Clusters: Results From the TULIP Study.
    Diabetes. 2026 Apr 13:db250757. doi: 10.2337/db25-0757.
    PubMed         Abstract available
    
    

    
    Diabetes Care

24. PASSOS PRC, Motta R, Oliveira Costa Filho V, Noronha MM, et al
    Hepatic Events Prevention by Antihyperglycemic Therapies and Intervention Comparisons in Type 2 Diabetes: The HEPATIC-T2DM Network Meta-analysis.
    Diabetes Care. 2026 Apr 13:dc260336. doi: 10.2337/dc26-0336.
    PubMed         Abstract available
    
    
25. O'BRIEN MJ, Formagini T
    Addressing Health-Related Social Needs in Diabetes Care: Increasing Our Stride Toward Health Equity?
    Diabetes Care. 2026 Apr 13:dci250090. doi: 10.2337/dci25-0090.
    PubMed         Abstract available
    
    
26. ROSEN VOLLMAR AK, Hedderson MM, Ngo AL, Chehab RF, et al
    Early Pregnancy Central Obesity and Risk of Prenatal and Postpartum Diabetes and Hypertensive Disorders.
    Diabetes Care. 2026 Apr 13:dc252812. doi: 10.2337/dc25-2812.
    PubMed         Abstract available
    
    
27. SAN DIEGO ERN, Aceves B, Gallo LC, McCurley JL, et al
    Nonmedical Factors That Influence Diabetes Complications and Multilevel Strategies to Reduce Disparities and Improve Outcomes in the U.S.
    Diabetes Care. 2026 Apr 13:dci250091. doi: 10.2337/dci25-0091.
    PubMed        
    
    
28. NAUCK M, Gribble F, Reimann F, D'Alessio DA, et al
    Clinical Potential of GIP in Type 2 Diabetes and Obesity.
    Diabetes Care. 2026 Apr 13:dci250141. doi: 10.2337/dci25-0141.
    PubMed         Abstract available
    
    
29. PAREEK M, Lassen MCH, Johansen ND, Christensen SH, et al
    Bivalent RSV Prefusion F Protein-Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial.
    Diabetes Care. 2026 Apr 14:dca260020. doi: 10.2337/dca26-0020.
    PubMed        
    
    
30. PARENTE EB, Jansson Sigfrids F, Groop PH, Thorn LM, et al
    Waist-to-Height Ratio Is Associated With the Risk of Coronary Artery Disease in Type 1 Diabetes: A 19-Year Cohort Study.
    Diabetes Care. 2026 Apr 14:dc252811. doi: 10.2337/dc25-2811.
    PubMed         Abstract available
    
    
31. TOKI R, Sakamoto M, Yuki M, Iida M, et al
    Seasonal BMI Amplitude and Risk of Kidney Function Decline in Japanese Adults With Type 2 Diabetes (JDDM 82).
    Diabetes Care. 2026 Apr 14:dc260082. doi: 10.2337/dc26-0082.
    PubMed         Abstract available
    
    
32. ZUPA M, Wormwood J, Qian S, Vimalananda V, et al
    Glycemic Outcomes of Endocrinology Consultation for Type 2 Diabetes by Visit Modality: A Retrospective Cohort Study.
    Diabetes Care. 2026 Apr 17:dc251134. doi: 10.2337/dc25-1134.
    PubMed         Abstract available
    
    
33. LI J, Shao X, Ou Y, Tan Z, et al
    Diabetes and Vitiligo.
    Diabetes Care. 2026 Apr 17:dc260488. doi: 10.2337/dc26-0488.
    PubMed        
    
    

    
    Diabetes Obes Metab

34. ISSACHAR A, Razi T, Borochov I, Duskin Bitan H, et al
    Association of Semaglutide Treatment With Liver Cirrhosis and Hepatocellular Carcinoma in Type 2 Diabetes: A Population-Based Cohort Study.
    Diabetes Obes Metab. 2026 Apr 13. doi: 10.1111/dom.70763.
    PubMed         Abstract available
    
    
35. ARMATO J, DeFronzo RA, Abdul-Ghani M, Ruby R, et al
    Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization (STOP DIABETES).
    Diabetes Obes Metab. 2026 Apr 13. doi: 10.1111/dom.70762.
    PubMed         Abstract available
    
    
36. CHEN JJ, Ho WY, Chen MT, Fang YW, et al
    Cardiorenal Outcomes of Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes Mellitus With Nephrotic-Range Proteinuria: A Multi-Institutional Target Trial Emulation.
    Diabetes Obes Metab. 2026 Apr 13. doi: 10.1111/dom.70764.
    PubMed         Abstract available
    
    
37. LI Y, Xu N, Zhao B, Duan Y, et al
    Dietary Fibre, Gut Microbiota and Cardiovascular Outcomes: Differential Associations by Diabetes Status in Multiethnic Cohorts.
    Diabetes Obes Metab. 2026 Apr 13. doi: 10.1111/dom.70754.
    PubMed         Abstract available
    
    
38. CHEN KE, Wang PC, Lin HA, Lin SF, et al
    Association of SGLT2 Inhibitor With Stroke in Type 2 Diabetes With Diabetic Retinopathy: A Multicenter Electronic Health Record Data Study.
    Diabetes Obes Metab. 2026 Apr 13. doi: 10.1111/dom.70744.
    PubMed         Abstract available
    
    
39. STUPALKOWSKA W, Henney AE, Riley DR, Sheu EG, et al
    Differential Impact of Metabolic Bariatric Surgery Versus Semaglutide on Adverse Hepatic and Extrahepatic Outcomes in Individuals With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Apr 13. doi: 10.1111/dom.70757.
    PubMed         Abstract available
    
    
40. LJUNGBERG C, Norgaard M, Vandenbroucke-Grauls C, Dalager-Pedersen M, et al
    Discontinuation of SGLT2i After a Urogenital Infection: A Population-Based Matched Cohort Study of Patients With Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Apr 14. doi: 10.1111/dom.70771.
    PubMed         Abstract available
    
    
41. LI T, Deng X, Miao Y, Zhang M, et al
    OGT Ameliorates Diabetes-Associated Cognitive Decline via Modulation of DRP1 Function and Mitochondrial Homeostasis.
    Diabetes Obes Metab. 2026 Apr 14. doi: 10.1111/dom.70758.
    PubMed         Abstract available
    
    
42. COSENTINO N, Krittanawong C, Pontone G
    Tirzepatide and Cardioprotection in Type 2 Diabetes: Insights From SURPASS-CVOT.
    Diabetes Obes Metab. 2026 Apr 15. doi: 10.1111/dom.70766.
    PubMed        
    
    
43. SHAH VN, Choudhary P, Halperin I, Rabbone I, et al
    Rethinking control-IQ+ technology: Simple strategies for easy optimization.
    Diabetes Obes Metab. 2026;28:3502-3514.
    PubMed         Abstract available
    
    
44. RATTARASARN I, Areevut C, Prachakeserane K, Chailurkit LO, et al
    Effects of Premeal Versus Postmeal Metformin Administration on Postmeal Glycemic Control in Individuals With Type 2 Diabetes Mellitus: A Randomized, 8-Week Crossover Study.
    Diabetes Obes Metab. 2026 Apr 17. doi: 10.1111/dom.70768.
    PubMed         Abstract available
    
    
45. ZACCARDI F, Aroda VR, Arslan EG, Bardtrum L, et al
    Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials.
    Diabetes Obes Metab. 2026 Apr 17. doi: 10.1111/dom.70770.
    PubMed         Abstract available
    
    
46. KWON D, Jung HJ, Nam J, Kim J, et al
    Optimising the Therapeutic Window: A Systematic Review and Network Meta-Analysis of Pregabalin Dosing Strategies for Painful Diabetic Neuropathy.
    Diabetes Obes Metab. 2026 Apr 13. doi: 10.1111/dom.70748.
    PubMed         Abstract available
    
    
47. RINEHIMER WOOLERY GR, Collins TC
    Nutrition and Exercise: A Scoping Review of Best Practices for Addressing Social Determinants of Health in the Management of Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Apr 13. doi: 10.1111/dom.70694.
    PubMed         Abstract available
    
    
48. LIM LL, Lau ESH, Lui JNM, Ji L, et al
    Impact of Simulated Risk Factor Management on Cardiovascular Disease and Costs in Type 2 Diabetes Using the ABC Model.
    Diabetes Obes Metab. 2026 Apr 13. doi: 10.1111/dom.70755.
    PubMed         Abstract available
    
    
49. ALMANDOZ JP, Ard JD, Gazda C, Edwards-Hampton S, et al
    Healthcare Resource Utilisation and Cost of Obesity and Related Complications in the United States: A Systematic Literature Review.
    Diabetes Obes Metab. 2026;28:4121-4136.
    PubMed         Abstract available
    
    
50. MOTTL AK, Khunti K, Mathieu C
    Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney disease.
    Diabetes Obes Metab. 2026;28:3568-3581.
    PubMed         Abstract available
    
    
51. HURTADO RL, Amato AA, de Luca Correa H, Silveira D, et al
    GLP-1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation.
    Diabetes Obes Metab. 2026;28:4185-4193.
    PubMed         Abstract available
    
    
52. YUAN M, Zhang Z, Chen Y, Lu C, et al
    The 1-Hour Plasma Glucose for Early Risk Stratification in Young, Obese Chinese Adults: Implications for Clinical Management.
    Diabetes Obes Metab. 2026;28:4276-4285.
    PubMed         Abstract available
    
    
53. ZHAO S, Qin P, Wang X, You Q, et al
    The GLP-1-miRNA network: Epigenetic control of obesity and metabolic disorders.
    Diabetes Obes Metab. 2026;28:3515-3534.
    PubMed         Abstract available
    
    
54. SHEN X, Luo S, Zheng J, Chui CSL, et al
    Evaluating the Impact of Putative Metformin Targets on Cancer Outcomes: A Drug-Target Mendelian Randomization Study.
    Diabetes Obes Metab. 2026;28:4091-4099.
    PubMed         Abstract available
    
    
55. VAN LAREN J, Friesleben C, Gershovich O, Helm L, et al
    Characterisation of real-world patients who discontinued a glucagon-like peptide-1 agonist.
    Diabetes Obes Metab. 2026;28:3965-3973.
    PubMed         Abstract available
    
    
56. SHAND J, Brosnahan N, Jiang Y, Murphy R, et al
    Uptake and early outcomes of a meal replacement intervention in an ethnically diverse adult population living with obesity and significant comorbidity.
    Diabetes Obes Metab. 2026;28:3924-3932.
    PubMed         Abstract available
    
    
57. RANJAN AG PHD, Laugesen C PhD, Boiroux D PhD, Schmidt S PhD, et al
    Performance of an automated insulin-glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single-blind randomised controlled crossover trial.
    Diabetes Obes Metab. 2026;28:3955-3964.
    PubMed         Abstract available
    
    
58. IZARRA A, Bermudez-Lopez M, Valdivielso JM, Pamplona R, et al
    Baseline and 4-year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort.
    Diabetes Obes Metab. 2026;28:3777-3787.
    PubMed         Abstract available
    
    

    
    Diabetologia

59. BLENCOWE M, Saleem Z, Liu R, Wang M, et al
    Multi-tissue multi-omics integration reveals tissue-specific pathways, gene networks and drug candidates for type 1 diabetes.
    Diabetologia. 2026 Apr 15. doi: 10.1007/s00125-026-06721.
    PubMed         Abstract available
    
    

    
    Eur J Endocrinol

60. HANSEN NW, Caci A, Wolfel EM, Sabaratnam R, et al
    Impaired insulin signaling limits osteogenic potential of bone marrow stromal cells in type 2 diabetes.
    Eur J Endocrinol. 2026 Apr 15:lvag063. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

61. HERNANDEZ KR, Pollock LM, Rodriguez AD, Lohr MF, et al
    Insulin Induces Outer Blood-Retinal Barrier Disruption via Downregulation of Claudin-19.
    Invest Ophthalmol Vis Sci. 2026;67:39.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

62. BU F, Wu R, Ostropolets A, Aminorroaya A, et al
    Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus.
    J Am Coll Cardiol. 2026 Apr 3:S0735-1097(26)05724.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

63. OSHIMA M, Hara A, Toyama T, Asayama A, et al
    Polygenic risk scores and lifestyle factors predicting new onset of type 2 diabetes in the Japanese general population.
    J Clin Endocrinol Metab. 2026 Apr 16:dgag171. doi: 10.1210.
    PubMed         Abstract available
    
    
64. PRAHALAD P, Zaharieva D, Maahs D
    Diabetes Technology: An Update.
    J Clin Endocrinol Metab. 2026 Apr 13:dgag164. doi: 10.1210.
    PubMed         Abstract available
    
    
65. MOHSEN M, Yi TW, Faruque L, Ke C, et al
    Combination Treatment for Management of Chronic Kidney Disease and Type 2 Diabetes: A Review and Practical Guidance.
    J Clin Endocrinol Metab. 2026 Apr 13:dgag163. doi: 10.1210.
    PubMed         Abstract available
    
    
66. BROSSFIELD AV, Williams KM, Kim TJ, Gjeci J, et al
    Sex- and Pubertal Stage-Specific Bone Microarchitecture and Strength in Adolescents With Type 1 Diabetes.
    J Clin Endocrinol Metab. 2026 Apr 11:dgag161. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Clin Invest

67. BACOS K, Perfilyev A, Karagiannopoulos A, Cowan E, et al
    Corrigendum to Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets.
    J Clin Invest. 2026;136:e206633.
    PubMed        
    
    
68. AMIEL SA, Zelaya FO
    Unconscious uncoupling: dysfunctional neurovascular responses to low glucose in type 1 diabetes and impaired hypoglycemia awareness.
    J Clin Invest. 2026;136:e205273.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

69. TANG H, Chen Z, Wang J, Meng H, et al
    Efficacy and hypoglycemia-related safety of henagliflozin or dapagliflozin as add-on to CSII in hospitalized patients with T2DM: A retrospective matched study using continuous glucose monitoring.
    J Diabetes Complications. 2026;40:109315.
    PubMed         Abstract available
    
    
70. LIU H, He J, Gao Y, Yan T, et al
    The association between reversion of prediabetes and incident cardiometabolic disease and mortality: A systematic review and meta-analysis.
    J Diabetes Complications. 2026;40:109272.
    PubMed         Abstract available
    
    

    
    JAMA

71. ANDERER S
    FDA Approves Weekly Basal Insulin for Adults With Type 2 Diabetes.
    JAMA. 2026 Apr 17. doi: 10.1001/jama.2026.2111.
    PubMed        
    
    
72. ABBASI J
    PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC.
    JAMA. 2026 Apr 10. doi: 10.1001/jama.2026.2399.
    PubMed        
    
    
73. ANDERER S
    Triple Agonist Reduces Hemoglobin A1C and Weight in Patients With Type 2 Diabetes.
    JAMA. 2026 Apr 10. doi: 10.1001/jama.2026.2107.
    PubMed        
    
    

    
    Metabolism

74. JIANG M, An X
    6-Phosphofructokinase-2/fructose-2,6-bisphosphatase 3: A potential target in the development of diabetes and its complications.
    Metabolism. 2026 Apr 14:156621. doi: 10.1016/j.metabol.2026.156621.
    PubMed         Abstract available
    
    
75. BAILEY CJ, Gwilt M, Brand KMG
    Metformin: Antidiabetic actions from cells to tissues.
    Metabolism. 2026;179:156589.
    PubMed         Abstract available
    
    
76. ZHANG H, Chen QF, Lip GYH, Tilg H, et al
    Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region.
    Metabolism. 2026;179:156575.
    PubMed         Abstract available
    
    

    
    N Engl J Med

77. NICHOLLS SJ, Pavo I, D'Alessio D
    Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes. Reply.
    N Engl J Med. 2026;394:10.
    PubMed        
    
    
78. ANKER MS, Butler J, Anker SD
    Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes.
    N Engl J Med. 2026;394:1551-1553.
    PubMed        
    
    
79. XU H, Cong X, Lin L
    Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes.
    N Engl J Med. 2026;394:1551.
    PubMed        
    
    
80. VAN BRUGGEN F
    Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes.
    N Engl J Med. 2026;394:1551.
    PubMed        
    
    
81. BECATTINI C, Agnelli G, Paciaroni M
    Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes.
    N Engl J Med. 2026;394:1550-1551.
    PubMed        
    
    
82. CHUAN F, Gao Y, Zhou B
    Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes.
    N Engl J Med. 2026;394:1550.
    PubMed        
    
    

    
    Nutr Metab (Lond)

83. PODRAZA J, Wasowski M, Jonas MI, Lisik W, et al
    Negative correlation between microRNA and insulin sensitivity gene expression in adipose tissue: potential implications for diabetes and neurodegenerative diseases.
    Nutr Metab (Lond). 2026 Apr 13. doi: 10.1186/s12986-026-01113.
    PubMed         Abstract available
    
    

    
    Pediatr Diabetes

84. CRONIN A, Dunne T, Gorman CO, Cremona A, et al
    Mapping Lifestyle Factors in Blood Glucose Variability in Adolescents With Type 1 Diabetes Mellitus: A Pilot Study.
    Pediatr Diabetes. 2026;2026:6257886.
    PubMed         Abstract available
    
    
85. MCVEAN J, Schiaffini R, Bassi M, Piccini B, et al
    Achieving Glycemic Targets in and out-of-School: Real-World Data From 1341 Italian Children Using the MiniMed 780G System During Auto Mode.
    Pediatr Diabetes. 2026;2026:1653728.
    PubMed         Abstract available
    
    

    
    Pediatrics

86. GUPTA M, Rutman LE, Carlin K, Mohsenian Y, et al
    Using Quality Improvement to Reduce Loss to Follow-Up in Pediatric Patients With Type 1 Diabetes.
    Pediatrics. 2026 Apr 16:e2025071042. doi: 10.1542/peds.2025-071042.
    PubMed         Abstract available
    
    

    
    PLoS One

87. TIAN X, Li J, Han T, Zhang L, et al
    DJ-1 alleviates high glucose-induced podocyte injury via activating ERK1/2 signaling.
    PLoS One. 2026;21:e0346714.
    PubMed         Abstract available
    
    
88. ZENG F, Liao Y, Jiang J, Zhao C, et al
    Unveiling the mechanism of calcitriol in treating type 2 diabetes mellitus: A combined network pharmacology and in vitro approach targeting ERS-related pathways.
    PLoS One. 2026;21:e0347246.
    PubMed         Abstract available
    
    
89. JAYANTI RP, Cho YS, Soedarsono S, Kim HJ, et al
    Correction: Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure.
    PLoS One. 2026;21:e0347490.
    PubMed         Abstract available
    
    
90. 
    Retraction: DiabetesXpertNet: An innovative attention-based CNN for accurate type 2 diabetes prediction.
    PLoS One. 2026;21:e0345989.
    PubMed        
    
    
91. ABDULWEHAB S, Kedir F
    Exploring barriers and enablers to diabetes self-care practice in Ethiopia, 2025: A qualitative systematic review.
    PLoS One. 2026;21:e0346867.
    PubMed         Abstract available
    
    
92. ELZAYAT A, Jilani R, Krimly A, Awan L, et al
    WHO five moments for medication safety among diabetic patients in Saudi Arabia.
    PLoS One. 2026;21:e0346935.
    PubMed         Abstract available
    
    

    
    Retina

93. ZHANG C, Bhatnagar A, Ersan S, Smiddy WE, et al
    Trends in the Management of Proliferative Diabetic Retinopathy in the First Year After Diagnosis.
    Retina. 2026 Apr 15. doi: 10.1097/IAE.0000000000004861.
    PubMed         Abstract available
    
    
94. DAI Z, Fan W, Yao Q, Liu K, et al
    Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Pars Plana Vitrectomy.
    Retina. 2026 Apr 15. doi: 10.1097/IAE.0000000000004859.
    PubMed         Abstract available
    
    

    
    Transplant Proc

95. EMARA A, Javed M, Khan AA, Needleman A, et al
    Outcomes After Kidney Transplantation From Deceased Donors With Diabetes.
    Transplant Proc. 2026 Apr 13:S0041-1345(26)00176.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum